Pharmaceutical Executive-12-01-2018

Features

January 30, 2019

Financial leaders from clinical-stage biopharma gather to discuss the critical role of finance and accounting (F&A) in supporting and sustaining the science at the forefront of engagement with investors.

The Commission’s gestures toward enacting formal standards to digitize health records are masking wider policy gaps.

Pharmaceutical Executive

Almost a year and a half later, key understandings have emerged to help companies better combat future data-breach attempts.

Pharmaceutical Executive

While the increasing importance of real-world evidence (RWE) is widely acknowledged, the dramatic shift required by pharma to embed meaningful and holistic benefits from this capability is still a work in progress.

Pharmaceutical Executive

Sonalee Agarwal, head of value and evidence strategy for Alnylam, talks with Pharm Exec about the role of real-world evidence in the rare and ultra-rare disease space.

Pharmaceutical Executive
From the Editor

December 10, 2018

In pharma, there may be hope that companies' and the industry's ability to adapt to change may finally be catching up to the pace of new and intelligent uses of technology and clinical data.

Pharmaceutical Executive

There is still no structured method of assessing pricing and access risk for drug manufacturers. Presented here is a straightforward measure for integrating pricing and access risk into portfolio planning and decision-making.

Pharmaceutical Executive

Objective considerations when gauging investment.

Issue PDF
Pharmaceutical Executive

December 01, 2018

Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.

Special Sponsored Section
Pharmaceutical Executive

December 01, 2018

With a reputation as a reliable, if somewhat unspectacular, marketplace, Malaysia has long appealed to life science investors lured in by the prospect of generating consistent returns.

Pharmaceutical Executive

Efforts intensify to bring outlays more in line with global trends.